DS

Dudley Strickland

University of Michigan: 8 patents #201 of 4,352Top 5%
UB University Of Maryland, Baltimore: 5 patents #67 of 1,115Top 7%
LR Ludwig Institute For Cancer Research: 5 patents #106 of 611Top 20%
UM University Of Maryland: 3 patents #50 of 857Top 6%
The General Hospital: 2 patents #806 of 3,021Top 30%
AC American National Red Cross: 2 patents #20 of 100Top 20%
EU Eastern Michigan University: 2 patents #14 of 37Top 40%
📍 Silver Spring, MD: #129 of 1,812 inventorsTop 8%
🗺 Maryland: #2,801 of 35,612 inventorsTop 8%
Overall (All Time): #445,865 of 4,157,543Top 15%
11
Patents All Time

Issued Patents All Time

Showing 1–11 of 11 patents

Patent #TitleCo-InventorsDate
12171802 Compositions for inhibiting fibrin-VLDL receptor-dependent inflammation and methods of treatment Leonid Medved, Sergiy B. Yakovlev 2024-12-24
10676527 Methods and compositions for modulation of blood-neural barrier Ulf Eriksson, Linda Fredriksson, Daniel A. Lawrence, Enming Joe Su, Manuel Yepes 2020-06-09
9926372 Methods and compositions for modulation of blood-neural barrier Ulf Eriksson, Linda Fredriksson, Daniel A. Lawrence, Enming Joe Su, Manuel Yepes 2018-03-27
9487579 Methods and compositions for modulation of blood-neural barrier Ulf Eriksson, Linda Fredriksson, Daniel A. Lawrence, Enming Joe Su, Manuel Yepes 2016-11-08
9096501 Plasminogen activator inhibitor-1 inhibitors and methods of use thereof to modulate lipid metabolism Daniel A. Lawrence, Jacqueline Cale, Enming Joe Su, Cory Emal, Mark Warnock 2015-08-04
8765671 Methods and compositions for modulation of blood-neural barrier Ulf Eriksson, Daniel A. Lawrence, Enming Joe Su, Manuel Yepes, Linda Fredriksson 2014-07-01
8759327 Plasminogen activator inhibitor-1 inhibitors and methods of use thereof to modulate lipid metabolism Daniel A. Lawrence, Jacqueline Cale, Enming Joe Su, Cory Emal, Mark Warnock 2014-06-24
8147828 Methods and compositions for modulation of blood-neural barrier Ulf Eriksson, Daniel A. Lawrence, Enming Joe Su, Manuel Yepes, Linda Fredriksson 2012-04-03
7375076 Methods of reducing vascular permeability in tissue by inhibition of tissue plasminogen activator (tPA) and tPA inhibitors useful therein Daniel A. Lawrence, Manuel Yepes 2008-05-20
6447775 Modulators of expression and function of LRP in Alzheimer's disease Bradley T. Hyman, Maria Z. Kounnas, Robert Moir, Rudolph E. Tanzi, G. William Rebeck 2002-09-10
6156311 Modulators of expression and function of LRP in alzheimer's disease Bradley T. Hyman, Maria Z. Kounnas, Robert Moir, Rudolph E. Tanzi 2000-12-05